Strategic Partnerships The company has actively pursued partnerships to expand access to autism assessments, including recent collaborations with Autism Testing 4 Kids (AT4K), Zest Pediatric Network, Netsmart, and ongoing engagements that aim to reduce diagnostic wait times and broaden service delivery.

Expansion Potential With multiple collaborations and a presence in payer and provider networks, there is a clear sales path to scale adoption of the EarliPoint System across pediatric clinics, diagnostic centers, and virtual evaluation platforms nationwide.

Technology Advantage The core offering—FDA-cleared eye-tracking technology for objective autism diagnosis—can be positioned to clinical stakeholders as a differentiator that complements standard evaluations, opening conversations with hospital systems, large practice groups, and telehealth networks.

Clinical Momentum Recent leadership changes and continued funding indicate growing organizational scale and stability, which can be leveraged to secure longer-term procurement contracts, service expansions, and training collaborations with pediatric practices.

Market Readiness The techenabled approach with partnerships across networks and digital marketing tools suggests readiness for procurement conversations with group purchasing organizations, health systems, and insurers seeking to reduce wait times and improve ASD screening workflows.